340B Drug Pricing Program
The AHA, along with other national hospital groups, is running a new digital ad campaign promoting to policymakers and influencers the benefits of the 340B program to patients and communities.
AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under the June 15 Supreme Court decision in American Hospital Association v. Becerra, without penalizing the rest of the hospital field.
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday filed a friend-of-the-court brief urging the U.S. Courts of Appeals for the 3rd Circuit to require drug companies to fulfill their legal obligations to…
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday filed a friend-of-the-court brief urging the U.S. Courts of Appeals for the 3rd Circuit to require drug companies to fulfill their legal obligations to…
AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under last week’s Supreme Court decision in American Hospital Association v. Becerra.
The Supreme Court of the United States unanimously ruled in favor of the AHA and others that the Department of Health and Human Services’ (HHS) policy to significantly cut payments by nearly 30% for certain hospitals that participate in the 340B Drug Pricing Program lacked statutory authority and…
The Supreme Court of the United States June 15 ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services (HHS) to significantly cut payments to certain hospitals that participate in the 340B…
The Supreme Court of the United States today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug…
The U.S. Supreme Court today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, and…
We are pleased that the U.S. Supreme Court unanimously agreed with us that the Department of Health and Human Services' outpatient payment cuts to hospitals in the 340B Drug Pricing Program were unlawful.